Skip to Main Content

Paper Details

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response.
Oncotarget
18
2018
ACC, ACC cell lines, CDK, CDK1, CDK1 protein, CDK2 mRNA, Human, Mice, XIAP, XIAP protein, adrenocortical carcinoma, cancer, cancer-related pathway arrays, carfilzomib, cleaved-caspase, cyclin-dependent kinase, flavopiridol, human, human ACC xenografts, mice, patients, rare cancers, three-dimensional tumor spheroids, tumor, tumor spheroids, tumor xenografts
Author NameAffiliation
Naris NilubolNational Cancer Institute, National Institutes of Health
Naris NilubolNational Cancer Institute, National Institutes of Health
Myriem BoufraqechNational Cancer Institute, National Institutes of Health
Myriem BoufraqechNational Cancer Institute, National Institutes of Health
Lisa ZhangNational Cancer Institute, National Institutes of Health
Lisa ZhangNational Cancer Institute, National Institutes of Health
Kelli GaskinsNational Cancer Institute, National Institutes of Health
Kelli GaskinsNational Cancer Institute, National Institutes of Health
Min ShenNational Center for Advancing Translational Sciences, National Institutes of Health
Min ShenNational Center for Advancing Translational Sciences, National Institutes of Health
Sudheer Kumar GaraNational Cancer Institute, National Institutes of Health
Sudheer Kumar GaraNational Cancer Institute, National Institutes of Health
Christopher P AustinNational Center for Advancing Translational Sciences, National Institutes of Health
Electron KebebewNational Cancer Institute, National Institutes of Health
Electron KebebewThe George Washington University School of Medicine and Health Sciences
Electron KebebewNational Cancer Institute, National Institutes of Health
Electron KebebewThe George Washington University School of Medicine and Health Sciences
  • 1 - 17

Datasets

Release 1.2